Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Top of the News-lir
Subscribe today for access to
Articles and Reports
Getting Started with the FDA’s New LDT Rule
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.
Transitioning the Clinical Lab
What clinical laboratory professionals need to know about healthcare provision for transgender and nonbinary patients
Mayo Clinic to Shut Down New England Laboratory
...
Already a member? Log in here
FDA Intervenes on Development of New Zika Test
...
Already a member? Log in here
Accumen Acquires Chi Solutions to Expand Laboratory Management, Consulting Business
From - Laboratory Industry Report
Accumen, Inc. (San Diego) specializes in "healthcare transformation," and now the company is transforming itself by joining forces with Chi Solutions (Ann Arbor, Mich.) to expand its clinical laboratory management and…
ACLA Pushing for Broadening of Coverage for Vitamin D Testing
...
Already a member? Log in here
CAP Issues New Guidelines for Reports on Bone Marrow Testing
...
Already a member? Log in here
Neoteryx–A Less Ambitious Version of Theranos?
...
Already a member? Log in here
FDA Issues Informational Queries to Two Startup Labs
...
Already a member? Log in here
Smaller Publicly-Traded Labs Report Mixed Results
...
Already a member? Log in here
Veritas Launches Below-$1,000 Whole Genome Test
From - Laboratory Industry Report
Veritas Genetics is launching a whole genome test under the four-figure price point…
